New England Journal of Medicine Avastin in Lung Cancer
New England Journal of Medicine Publishes Data from Pivotal Study of Avastinterm Plus Chemotherapyterm in Most Common Type of Lung Cancer  Genentech, Inc. (NYSE-DNA) announced today the publication...
View ArticlePhase II Trial Results Positive in Non-small Cell Lung Cancer For AS1404
   Presented at the EORTC-NCI-AARC (European Organization for Research and Treatment of Cancer; National Cancer Institute; American Association for Respiratory Care) meeting in Prague in November,...
View ArticlePositive Phase II Trial Results for AS1404 in Ovarian Cancer Patients
   Presented at the International Gynecological Cancer Society (IGCS) in Santa Monica in October, Antisoma reported positive tumor response data in a phase II ovarian cancer trial. With AS1404...
View ArticleTaxol-type drugs give slight boost to survival rates in early breast cancer
The breast cancer drugs called taxanes, which include Taxol (paclitaxel) and Taxotere (docetaxel), increase survival rates when used as part of chemotherapyterm following surgery for cancers that have...
View Article